Mibefradil prevents neointima formation after vascular injury in rats: Possible role of the blockade of the T-type voltage-operated calcium channel

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 15, Issue 8, 1995, Pages 1161-1165

  Schmitt, R ^a,b   Clozel, J P ^b   Iberg, N ^b   Buhler F R ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

calcium channel antagonist; cell proliferation, smooth muscle; mibefradil; rats; vascular injury

Indexed keywords

CALCIUM ANTAGONIST; CALCIUM CHANNEL; MIBEFRADIL;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL INJURY; CAROTID ARTERY DISEASE; CELL PROLIFERATION; CHANNEL GATING; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0029093659     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.15.8.1161     Document Type: Article

References (31)

1. Bean BP. Classes of calcium channels in vertebrate cells. Annu Rev Physiol. 1989;51:367-384.
2. Hermsmeyer K. Differences of calcium channels in vascular muscle in hypertension. Am J Hypertens. 1991;4:412S-415S.
3. Tsien RW, Lipscombe D, Madison DV, Bley KR, Fox AP. Multiple types of neuronal calcium channels and their selective modulation. Trends Neurosci. 1988;11:431-438.
4. Chen CF, Corbley MJ, Roberts TM, Hess P. Voltage-sensitive calcium channels in normal and transformed 3T3 fibroblasts. Science. 1988;239:1024-1026.
5. Estacion M. Characterization of ion channels seen in subconfluent human dermal fibroblasts. J Physiol. 1991;436:579-601.
6. 2 receptor modulates T-type calcium current in nondifferentiated NG108-15 cells. FEBS Lett. 1992;209:161-164.
7. Furukawa T, Ito H, Nitta J, Tsujino M, Adachi S, Hiroe M, Marumo F, Sawanobori T, Hiraoka M. Endothelin-1 enhances calcium entry through T-type calcium channels in cultured neonatal rat ventricular myocytes. Circ Res. 1992;71:1242-1253.
8. 2+ influx via T-type channels modulates PDGF-induced replication of mouse fibroblasts. Am J Physiol. 1993;865(Cell Physiol. 34):C1239-C1246.
9. 2+ channel blocker with potent vasodilator but weak inotropic action. J Cardiovasc Pharmacol. 1989;13:754-759.
10. Clozel JP, Osterrieder W, Kleinbloesem CH, Welker HA, Schläppi B, Tudor R, Hefti F, Schmitt R, Eggers H. Ro 40-5967: a new nondihydropyridine calcium antagonist. Cardiovasc Drug Rev. 1991; 9:4-17.
11. 3H] desmethoxyverapamil receptor, is devoid of the negative inotropic effects of verapamil in normal and failing rat hearts. Cardiovasc Drugs Ther. 1990;4:731-736.
12. Véniant M, Clozel JP, Hess P, Wolfgang R. Ro 40-5967, in contrast to diltiazem, does not reduce left ventricular contractility in rats with chronic myocardial infarction. J Cardiovasc Pharmacol. 1991; 17:277-284.
13. 2+ channels by Ro 40-5967. Circ Res. 1994;75:144-148.
14. Bean BP. Pharmacology of calcium channels in cardiac muscle, vascular muscle, and neurons. Am J Hypertens. 1991;4:406S-411S.
15. Clowes AW, Clowes MM. The influence of hypertension on injury-induced myointimal thickening. Surgery. 1980;88:254-259.
16. Clowes AW, Reidy MA, Clowes MM. Kinetic of cellular proliferation after arterial injury. Lab Invest. 1983;49:327-334.
17. Clozel JP, Müller RKM, Roux S, Fischli W, Baumgartner HR. Influence of the status of the renin-angiotensin system on the effect of cilazapril on neointima formation after vascular injury in rats. Circulation. 1993;88:1222-1227.
18. Gerold M, Tschirky H. Measurement of blood pressure in unanesthetized rats and mice. Arzneim-Forsch/Drug Res. 1969;18: 1285-1287.
19. Haudenschild CC, Schwartz SM. Endothelial regeneration: II. restitution of endothelial continuity. Lab Invest. 1979;41:407-418.
20. Scott-Burden T, Resink TJ, Baur U, Bürgin M, Bühler FR. Epidermal growth factor responsiveness in smooth muscle cells from hypertensive and normotensive rats. Hypertension. 1989;13:295-304.
21. Schmitt R, Kleinbloesem CH, Belz GG. Hemodynamic and humoral effects of the novel calcium antagonist Ro 40-5967 in patients with hypertension. Clin Pharmacol Ther. 1992;52:314-323.
22. Powell JS, Clozel JP, Müller RKM, Kuhn H, Hefti F, Hosang M, Baumgartner HR. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science. 1989;245:186-188.
23. Cook NS, Rudin M, Zerwes HG, Pally C, Lekoape K, Tschopp K, Peter J, Hof R. Anti-proliferative effect of spirapril and isradipine following balloon catheter injury of the rat carotid artery. Basel, Switzerland: The Second International Symposium of Calcium Antagonists in Cardiovascular Care; 1991. Abstract.
24. Jackson CL, Bush RC, Bowyer DE. Inhibitory effect of calcium antagonists on balloon catheter-induced arterial smooth muscle cell proliferation and lesion size. Atherosclerosis. 1988;69:115-122.
25. 2+ current is expressed in hypertrophied adult feline left ventricular myocytes. Circ Res. 1993;73: 777-782.
26. 2+ channels are abnormal in genetically determined cardiomyopathic hamster hearts. Circ Res. 1994;75: 149-155.
27. Xu X, Best PM. Postnatal changes in T-type calcium current density in rat atrial myocytes. J Physiol., London. 1992;454:657-672.
28. Mercadier JJ, Lompre AM, Wisnewsky C, Samuel JL, Bercovici J, Swynghedauw B. Myosin isoenzymic changes in several models of rat cardiac hypertrophy. Circ Res. 1981;49:525-532.
29. Zhou Z, Lipsius SL. T-type calcium current in latent pacemaker cells isolated from cat right atrium. J Mol Cell Cardiol. 1994;26: 1211-1219.
30. 2+ channels in canine cardiac purkinje cells. Circ Res. 1992;70:456-464.
31. The MERCATOR Study Group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Circulation. 1992;86:100-110.